SS Innovations International (NASDAQ: SSII) Is ‘One to Watch’ – InvestorBrandNetwork (IBN) Content Platform

✎ Contributed by Ty Griffin

Clinically validated, advanced surgical robotics technology platform.
Differentiated SSi Mantra system attributes (e.g., cost advantages, cardiac and pediatric surgery capabilities, ease of use and training, and pioneering telesurgery features).
Large and growing addressable market with favorable industry tailwinds.
Stronghold in India, global expansion underway, and potential catalysts in the US and EU.
World-class R&D and manufacturing facilities to support growth.
Robust sales growth, expanding margins, and increasing mix of recurring revenue.
Aligned, accomplished management team and Board of Directors.

SS Innovations International (NASDAQ: SSII) develops differentiated surgical robotic technologies, highlighted by its advanced, cost-efficient SSi Mantra surgical robotic system. Spearheaded by a team of visionary engineers and Dr. Sudhir Srivastava, an acclaimed robotic cardiac surgeon and the company’s founder, Chairman and Chief Executive Officer, the SSi Mantra features differentiated capabilities in areas such as telesurgery, cardiac surgery and pediatric procedures. The SSi Mantra’s broad-based surgical robotic applications, modularity, user friendliness, training capabilities, clinical track record and relative cost advantages have contributed to its early commercial success.

SS Innovations is a rapidly growing American company headquartered in India and expanding globally with an eye on democratizing access to cutting-edge surgical robotic technologies. After commencing commercial operations in late 2022, the company’s annual revenue has grown from approximately…